Syndex Bio announced it raised $15.5 Million in an initial filing from an offering of $15.5 Million

Company

Location

About

Syndex Bio is a pioneering company dedicated to unlocking new insights in biology by integrating molecular technologies, instrumentation, and AI. Having developed transformative tools for the genomics era, Syndex Bio understands the profound impact of disruptive innovations on biological discovery and healthcare. By building a powerful platform, the company accelerates the understanding, diagnosis, and treatment of disease, driving the next generation of advancements in medical science.